Our synthesized findings suggest no significant association between ANA positivity and mortality in pSS-ILD, with an HR of 0.55 (95%CI 0.26–1.18, P = 0.13) and low heterogeneity (I2 < 50%) (Fig. 3a). This evidence concerns the gene BTG3 and interstitial lung disease.